zolpidem (Ambien)

Subscribe to Selected New Research on zolpidem

334 relevant articles (46 outcomes, 73 trials/studies) found for this Drug

Description: an azabicyclo(4.3.0)nonane; a nonbenzodiazepine; benzodiazepine receptor agonist; RN given from Toxline; RN not in Chemline 12/85; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; structure given in first source

Also Known As:

Ambien; Stilnox; zolpidem tartrate; 1A brand of zolpidem tartrate; AWD brand of zolpidem tartrate; AbZ brand of zolpidem tartrate; Allphar brand of zolpidem tartrate; Amsic; Atlanta Pharma brand of zolpidem tartrate; BC brand of zolpidem tartrate; Bikalm; Dalparan; Farma Lepori brand of zolpidem tartrate; Hexal brand of zolpidem tartrate; Krewel brand of zolpidem tartrate; Lichtenstein brand of zolpidem tartrate; Merck dura brand of zolpidem tartrate; N,N,6-trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate; SL 80.0750; SL-800750-23-N; Sanofi Synthelabo brand of zolpidem tartrate; Sanofi brand of zolpidem tartrate; Stilnoct; Zoldem; Zolirin; Zolpi-Lich; Zolpidem 1A Pharma; Zolpidem AbZ; Zolpinox; zodormdura

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Pyridines: 26

zolpidem: 334

Experts

1.	Walsh, James K: 5 articles (06/2008 - 10/2002)
2.	Roth, Thomas: 4 articles (09/2008 - 08/2006)
3.	Scharf, Martin B: 2 articles (09/2008 - 10/2004)
4.	Cubała, Wiesław J: 2 articles (03/2008 - 03/2007)
5.	Landowski, Jerzy: 2 articles (03/2008 - 03/2007)
6.	Krystal, Andrew D: 2 articles (01/2008 - 08/2004)
7.	Smerieri, Arianna: 2 articles (01/2008 - 01/2003)
8.	Terzano, Mario Giovanni: 2 articles (01/2008 - 01/2003)
9.	Parrino, Liborio: 2 articles (01/2008 - 01/2003)
10.	Soubrane, Christina: 2 articles (01/2008 - 08/2006)

Related Diseases

1.	Sleep Initiation and Maintenance Disorders (Insomnia) 05/18/2007 - "Zolpidem has been known as a very safe and effective hypnotic drug used to treat a variety of patients with insomnia" 08/01/2004 - "CONCLUSIONS: Over a period of 12 weeks of intermittent treatment with zolpidem, sleep continuity was significantly improved, the clinical gains were sustained, and there was no evidence of subjective rebound insomnia between doses or increases in the amount of medication used during the study interval." 10/01/2008 - "CONCLUSIONS: Employed adults with chronic insomnia treated with zolpidem extended-release 12.5 mg experienced significantly improved work performance over 24 weeks." 12/15/2000 - "CONCLUSIONS: In agreement with previous findings obtained in patients with chronic primary insomnia, zolpidem significantly improved sleep induction and maintenance" 01/01/2004 - "All three studies demonstrated that zolpidem can be used effectively and safely on a non-daily basis in individuals with chronic insomnia" Order ALL the reference details at left...
2.	Brain Injuries (Brain Injury) 08/01/2004 - "The authors postulate a central mechanism of action by selective inhibition of GABAergic inhibitory neurons, and suggest a controlled clinical study to investigate the potential efficacy of zolpidem in relieving spasticity related to postanoxic brain injury." 01/01/2004 - "After zolpidem, cerebral perfusion through brain injury areas improved substantially in three patients and the cerebellar diaschisis was reversed" 01/01/2008 - "CASE STUDY: This study treated a 44 year old male with MCS some 4 years after his traumatic brain injury with zolpidem for 1 week on and 1 week off treatment" 01/01/2004 - "The study investigates the effect of zolpidem (CAS 82626-48-0) on brain injuries and cerebellar diaschisis" 03/01/2008 - "Increased arousal in a patient with anoxic brain injury after administration of zolpidem." Order ALL the reference details at left...
3.	Sleep Disorders 07/01/2002 - "With discontinuation of zolpidem and effective treatment of their sleep disorders, nocturnal eating resolved" 04/01/1992 - "The safety and efficacy of 10 or 20 mg/day zolpidem, a new hypnotic belonging to the imidazopyridine class, were studied over a 180-day period in 96 patients with sleep disorders" 01/01/2004 - "Use of zolpidem in over 75-year-old patients with sleep disorders and comorbidities." 07/01/2002 - "CONCLUSIONS: Zolpidem, at least in patients with underlying sleep disorders that cause frequent arousals, may cause or augment sleep-related eating behavior" 01/01/2001 - "Zolpidem (ivadal) treatment of sleep disorders]" Order ALL the reference details at left...
4.	Seizures (Seizure) 06/01/2008 - "Zolpidem (10 mg/kg) produced similar enhancements of the seizure threshold in adult and aged mice" 03/30/2007 - "Several case reports of zolpidem abuse and dependence have been published along with a small number of cases demonstrating seizures after sudden zolpidem withdrawal" 03/30/2007 - "Seizure following sudden zolpidem withdrawal." 07/01/2004 - "On the other hand, administration of zolpidem (1 mM) was without significant effects on the mortality rate, the incidence and latency of the tonic seizure" 09/01/2000 - "At the clinical level, it is stressed that the subjective effects ofzolpidem are comparable to those of other BZs, and that abuse, dependence, and withdrawal seizures cannot be avoided simply shifting the regimen of a BZ abuser to zolpidem" Order ALL the reference details at left...
5.	Syndrome 10/01/2008 - "Our case demonstrates that zolpidem may be beneficial in the long term treatment of idiopathic central sleep apnoea syndrome." 10/01/2008 - "Idiopathic central sleep apnoea syndrome treated with zolpidem." 03/01/2008 - "Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects." 03/01/2004 - "The effects of zolpidem on GABAA receptor gene expression are consistent with the reduced tolerance liability of this drug as well as with other ability to induce both physical dependence and withdrawal syndrome" 07/01/2002 - "We have observed three patients with abuse, dependence and withdrawal syndrome to zolpidem" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Benzodiazepines
2.	zaleplon (Sonata)
3.	Triazolam (Halcion)
4.	Hypnotics and Sedatives (Sedatives)
5.	Flunitrazepam (Rohypnol)
6.	zopiclone (Zop)
7.	Temazepam (Nocturne)
8.	gamma-Aminobutyric Acid (GABA)
9.	Trazodone (Trittico)
10.	Flurazepam (Dalmane)

Related Therapies and Procedures

1.	Continuous Positive Airway Pressure
2.	Aftercare (After-Treatment)
3.	Drug Therapy (Chemotherapy)
4.	Palliative Care (Palliative Medicine)
5.	Hypnosis (Mesmerism)

Best Treatments:
Research Summary Report
on Sleep Initiation and Maintenance Disorders

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 299 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>